| Literature DB >> 31727235 |
Sara Valpione1, Luca Campana2.
Abstract
Circulating tumor DNA (ctDNA) analyses are minimally invasive and accessible for risk stratification or treatment response monitoring of cancer patients. Compared to tumor biopsy analysis, they are not only less invasive, but also provide a more representative picture, allowing capturing both tumor heterogeneity and multiple tumor sites. Development of new technologies such as droplet-based digital PCR (ddPCR) has greatly improved the sensitivity, specificity and precision of the detection of rare ctDNA sequences in the pool of total circulating free DNA. In this chapter, we discuss the application of ddPCR in the analysis of ctDNA, and present the protocols for obtaining variant allele frequency or copy number variation analysis.Entities:
Keywords: Cancer; Circulating tumor DNA; Digital droplet PCR; Liquid biopsy; Minimal residual disease; Oncology; ctDNA
Mesh：
Substances：
Year: 2019 PMID： 31727235 DOI： 10.1016/bs.mie.2019.08.002
Source DB: PubMed Journal: Methods Enzymol ISSN： 0076-6879 Impact factor: 1.600